Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear filters
Book

MAO Inhibitors

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

MAO Inhibitors

Mohamed A. Sabri et al.
Free Books & Documents

Excerpt

Monoamine oxidase inhibitors (MAO Inhibitors) are medications used to manage and treat depression, among other neurological and psychiatric illnesses. It is in the Antidepressants class of drugs. This activity reviews the indications, action, and contraindications of the commonly prescribed MAO Inhibitors as a valuable agent in managing depression and other neuropsychiatric disorders. This activity will highlight the mechanism of action, adverse event profile, and other key factors such as off-label use, administration, and relevant molecular interactions pertinent for the interprofessional team members involved in the care of patients with depression and related conditions.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Mohamed Sabri declares no relevant financial relationships with ineligible companies.

Disclosure: Maha Saber-Ayad declares no relevant financial relationships with ineligible companies.

Similar articles

References

    1. López-Muñoz F, Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009;15(14):1563-86. - PubMed
    1. Menkes D, Bosanac P, Castle D. MAOIs - does the evidence warrant their resurrection? Australas Psychiatry. 2016 Aug;24(4):371-3. - PubMed
    1. Stein DJ, Ipser JC, Balkom AJ. Pharmacotherapy for social phobia. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001206. - PubMed
    1. Nelson JC, Spyker DA. Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000-2014. Am J Psychiatry. 2017 May 01;174(5):438-450. - PubMed
    1. Thase ME. The role of monoamine oxidase inhibitors in depression treatment guidelines. J Clin Psychiatry. 2012;73 Suppl 1:10-6. - PubMed

Publication types

LinkOut - more resources